Charming Medical director files initial ownership

Charming Medical Ltd director Yu Shu Tai Victor has filed an initial statement of beneficial ownership on Form 3.

Accepted by SEC EDGAR 03/27/2026 - 07:08 AM EDT

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Charming Medical Ltd director Yu Shu Tai Victor has filed an initial statement of beneficial ownership on Form 3. The filing does not report any insider stock transactions or list any derivative positions for this director at Charming Medical Ltd.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Charming Medical Ltd (MCTA) Form 3 filing report?

The Form 3 for Charming Medical Ltd reports that Yu Shu Tai Victor is a director and provides an initial statement of beneficial ownership. It does not list any stock transactions or derivative positions for this insider at the time of the filing.

Who is the reporting person in Charming Medical Ltd (MCTA) Form 3?

The reporting person is Yu Shu Tai Victor, identified as a director of Charming Medical Ltd. The filing confirms his board role but does not show any associated stock transactions or derivative security holdings for him in this initial statement.

Does the Charming Medical Ltd (MCTA) Form 3 show any insider stock trades?

No, the Form 3 filing shows zero insider stock transactions for Yu Shu Tai Victor. Transaction counts for buys, sells, exercises, gifts, tax withholdings, and restructurings are all reported as zero in the summarized data for this initial ownership statement.

Are any derivative securities disclosed for MCTA’s director in this Form 3?

No derivative securities are disclosed for Yu Shu Tai Victor in this Form 3. The derivative section is empty and the derivative transaction count is zero, indicating no options, warrants, or similar instruments reported in this initial beneficial ownership filing.

What is the net buy or sell direction in the MCTA Form 3 data?

The summarized data for Charming Medical Ltd’s Form 3 shows a neutral net buy or sell direction. Buy and sell share counts are both zero, and there are no derivative exercises or other transactions reported for director Yu Shu Tai Victor.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

YU SHU TAI VICTOR

(Last)

(First)

(Middle)

UNITS 1803-1806, 18/F, HANG LUNG CENTRE

2-20 PATERSON STREET, CAUSEWAY BAY

(Street)

HONG KONG

00000

(City)

(State)

(Zip)

HONG KONG

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Charming Medical Ltd [ MCTA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

No securities are beneficially owned.

	/s/ Yu Shu Tai Victor	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR